IBD Science for Patients

For years, people living with inflammatory bowel disease (IBD) have been given a strict rule: “Avoid NSAIDs.” These common painkillers, which include everyday medicines like ibuprofen and naproxen, have long been blamed for triggering “flares” and damaging the gut lining.

However, a massive new study presented at the 2026 Crohn’s and Colitis Congress is starting to change the conversation. The research suggests that while caution is still needed, a total ban on these medicines might be leaving some patients in unnecessary pain.

What the Research Found

This was a very large-scale retrospective study that looked at the medical records of 271,236 patients with IBD. To get a clear picture of how these drugs affect the gut over time, the researchers analysed data spanning 22 years, from 2000 to 2022.

The results showed that the risk isn’t the same for everyone:

• Ulcerative Colitis (UC): In patients with UC, taking a prescription NSAID was not linked to a significant increase in hospitalisations. For these patients, the drugs appeared to be much safer than previously thought.
• Crohn’s Disease: For those with Crohn’s, the risk was slightly higher. These patients had a 16% increased risk of a flare severe enough to need a hospital visit.
• A “Grey Zone”: Overall, while there was a tiny increase in risk across the whole IBD group, researchers described it as “numerically small” – meaning the benefit of the pain relief might outweigh the small risk to the gut for some people.

Why This Matters to You as a Patient

If you live with Crohn’s or Colitis, you probably know that the disease doesn’t just stay in your gut. Many patients suffer from joint pain, arthritis, and inflammation.

1. More Tools for Pain: Until now, many IBD patients felt they only had one option for pain: paracetamol. This research opens the door for you to have a nuanced conversation with your doctor about using specific types of NSAIDs, like COX-2 inhibitors, for short periods to manage joint pain.
2. Personalised Choices: The study proves that IBD isn’t “one size fits all.” Because the risk was lower for UC patients, your treatment plan might be able to be tailored to your specific type of IBD.
3. Better Quality of Life: By potentially allowing these medications in a controlled way, doctors can better treat the “invisible” symptoms of IBD, like aching joints, helping you stay active and feel better day-to-day.

Important: You should still always talk to your specialist before starting any NSAID, as they may only be safe when your IBD is in remission.